{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:06:36Z","timestamp":1789765596516,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.eprac.2026.08.014","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T06:58:06Z","timestamp":1787122686000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thyroid Year-in-Review 2025-2026: Precision Medicine and De-escalation in Contemporary Thyroidology"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4500-8546","authenticated-orcid":false,"given":"Anupam","family":"Kotwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Chindris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaniksha","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"El Kawkgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malini","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchie","family":"Jaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rokshana","family":"Thanadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.eprac.2026.08.014_bib1","doi-asserted-by":"crossref","first-page":"e4137","DOI":"10.1210\/clinem\/dgaf208","article-title":"Assessing the cardiovascular effects of levothyroxine use in an ageing United Kingdom population (ACEL-UK): cohort study","volume":"110","author":"Holley","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.eprac.2026.08.014_bib2","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1177\/10507256251393523","article-title":"Hypothyroidism and risks of all-cause and cardiovascular mortality: a retrospective cohort study of 70,276 Chinese adults","volume":"35","author":"Ran","year":"2025","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.eprac.2026.08.014_bib3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.eprac.2023.05.002","article-title":"Levothyroxine dosing in older adults: recommendations derived from the Baltimore Longitudinal Study of Aging","volume":"29","author":"Gavigan","year":"2023","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.eprac.2026.08.014_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/thy.2024.0604","article-title":"Sex differences in risk for iatrogenic thyrotoxicosis among older adults: an analysis from real-world clinical data","volume":"35","author":"Adams","year":"2025","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.eprac.2026.08.014_bib5","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1210\/clinem\/dgae294","article-title":"TSH trajectories during levothyroxine treatment in the Brazilian longitudinal study of adult health (ELSA-Brasil) cohort","volume":"109","author":"Ettleson","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.014_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eprac.2025.07.023","article-title":"Lower serum triiodothyronine levels constitute an independent risk factor for dyslipidemia in levothyroxin-treated patients","volume":"32","author":"Penna","year":"2026","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2026.08.014_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1522753","article-title":"A feasibility double-blind trial of levothyroxine vs. levothyroxine-liothyronine in postsurgical hypothyroidism","volume":"16","author":"Phan","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"10.1016\/j.eprac.2026.08.014_bib8","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1210\/clinem\/dgaf449","article-title":"Risk of death and adverse effects in patients on liothyronine: a multisource systematic review and meta-analysis","volume":"110","author":"Bahl","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.014_bib9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1210\/clinem\/dgaf367","article-title":"Treatment of hypothyroidism that contains liothyronine is associated with reduced risk of dementia and mortality","volume":"111","author":"Beltr\u00e3o","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.014_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eprac.2025.09.007","article-title":"Use of the 36-point thyroid symptom questionnaire to potentially guide optimal thyroid hormone replacement therapy","volume":"32","author":"Hoang","year":"2026","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.eprac.2026.08.014_bib11","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-24-0373","article-title":"Severity of thyrotoxicosis is a risk factor for excessive weight gain in treated hyperthyroidism","volume":"14","author":"Kyriacou","year":"2025","journal-title":"Eur Thyroid J"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.014_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/10507256251404868","article-title":"Weight gain after treatment of hyperthyroidism is associated with impairment of quality of life","volume":"36","author":"Kyriacou","year":"2026","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.eprac.2026.08.014_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-098238","article-title":"In the shadow of Graves\u2019 disease: a qualitative interview study of patients\u2019 experiences conducted at a secondary referral centre in Sweden","volume":"15","author":"Lindo","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.eprac.2026.08.014_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.eprac.2026.05.005","article-title":"Long-term antithyroid drug therapy in the management of Graves\u2019 hyperthyroidism: an updated narrative review","author":"Azizi","year":"2026","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.014_bib15","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1210\/clinem\/dgaf433","article-title":"Impact of minimal dose strategy before antithyroid drug discontinuation on relapse risk in Graves\u2019 disease","volume":"111","author":"Miyamura","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2026.08.014_bib18","series-title":"An open-label biomarker study of BHV-1300 in Graves\u2019 disease","year":"2025"},{"issue":"4","key":"10.1016\/j.eprac.2026.08.014_bib20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/jamaophthalmol.2021.6284","article-title":"Proptosis and diplopia response with teprotumumab and placebo vs the recommended treatment regimen with intravenous methylprednisolone in moderate to severe thyroid eye disease: a meta-analysis and matching-adjusted indirect comparison","volume":"140","author":"Douglas","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.014_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/10507256251408731","article-title":"Corticosteroids versus teprotumumab for the treatment of thyroid eye disease. Does either mitigate the need for additional treatments?","volume":"36","author":"Choi","year":"2026","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.eprac.2026.08.014_bib22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/thy.2024.0629","article-title":"Factors associated with response to intravenous glucocorticoids in active moderate-to-severe thyroid eye disease","volume":"35","author":"Baczewska","year":"2025","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.eprac.2026.08.014_bib23","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ophtha.2025.05.012","article-title":"Long-term cardiovascular, renal, and safety outcomes of teprotumumab versus systemic glucocorticoids in thyroid eye disease: a target trial emulation","volume":"132","author":"Lo","year":"2025","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.eprac.2026.08.014_bib24","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1177\/10507256251364782","article-title":"Early statin use following diagnosis of Graves\u2019 disease is associated with a reduced risk of moderate-to-severe Graves\u2019 orbitopathy in middle-aged adults: evidence from a Nationwide Taiwanese Cohort","volume":"35","author":"Chou","year":"2025","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.eprac.2026.08.014_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/thy.2024.0338","article-title":"Radiofrequency ablation for solitary autonomously functioning thyroid nodules: multicenter study from Latin America","volume":"35","author":"Due\u00f1as","year":"2025","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.014_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.eprac.2025.09.197","article-title":"Quality of life after ethanol ablation of thyroid nodules: a 1-year follow-up study","volume":"32","author":"Scappaticcio","year":"2026","journal-title":"Endocr Pract"},{"issue":"9","key":"10.1016\/j.eprac.2026.08.014_bib27","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1177\/10507256251372166","article-title":"First-in-human clinical feasibility study of ablation of benign thyroid nodules using nanosecond pulsed field ablation","volume":"35","author":"Spiezia","year":"2025","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.eprac.2026.08.014_bib28","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaf117","article-title":"Safety and efficacy of pressure-enabled thyroid embolization: a novel approach for symptomatic thyroid disease","volume":"9","author":"Gad","year":"2025","journal-title":"J Endocr Soc"},{"issue":"12","key":"10.1016\/j.eprac.2026.08.014_bib29","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1177\/10507256251393520","article-title":"Quality of life following thermal ablation of benign thyroid nodules: a systematic review and meta-analysis","volume":"35","author":"Kowalski","year":"2025","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.eprac.2026.08.014_bib30","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1089\/thy.2023.0281","article-title":"General principles for the safe performance, training, and adoption of ablation techniques for benign thyroid nodules: an American Thyroid Association statement","volume":"33","author":"Sinclair","year":"2023","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.eprac.2026.08.014_bib31","doi-asserted-by":"crossref","first-page":"e2231","DOI":"10.1210\/clinem\/dgae112","article-title":"Outcomes of cytologically indeterminate thyroid nodules managed with genomic sequencing classifier","volume":"109","author":"Ahmadi","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2026.08.014_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/thy.2024.0455","article-title":"Thyroid nodules with indeterminate cytology and negative molecular profile: prevalence of malignancy and practice paradigms for surveillance","volume":"35","author":"Nachum","year":"2025","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.014_bib33","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/clinem\/dgac688","article-title":"Real-world performance of the afirma genomic sequencing classifier (GSC)\u2014a meta-analysis","volume":"108","author":"Nasr","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2026.08.014_bib34","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-25-0296","article-title":"Comparing the diagnostic accuracy of Afirma GSC to ThyroSeq V3 in cytologically indeterminate thyroid nodules","volume":"14","author":"Dowell","year":"2025","journal-title":"Eur Thyroid J"},{"issue":"5","key":"10.1016\/j.eprac.2026.08.014_bib35","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1089\/thy.2024.0584","article-title":"Combining ultrasound imaging and molecular testing in a multimodal deep learning model for risk stratification of indeterminate thyroid nodules","volume":"35","author":"Athreya","year":"2025","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.eprac.2026.08.014_bib36","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.eprac.2026.01.750","article-title":"Improving diagnostic precision in thyroid pathology by synergistic use of AI and molecular markers","volume":"32","author":"Azad","year":"2026","journal-title":"Endocr Pract"},{"issue":"8","key":"10.1016\/j.eprac.2026.08.014_bib37","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.eprac.2026.08.014_bib38","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2025.0033","article-title":"NCCN guidelines\u00ae insights: thyroid carcinoma, version 1.2025","volume":"23","author":"Haddad","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.014_bib39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00268-009-0303-0","article-title":"An observational trial for papillary thyroid microcarcinoma in Japanese patients","volume":"34","author":"Ito","year":"2010","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.014_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/thy.2013.0367","article-title":"Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation","volume":"24","author":"Ito","year":"2014","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.eprac.2026.08.014_bib41","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamasurg.2025.2957","article-title":"Long-term durability of active surveillance of small, low-risk papillary thyroid cancer","volume":"160","author":"Sawka","year":"2025","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.eprac.2026.08.014_bib42","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00330-025-11873-x","article-title":"Propensity-matched comparison of microwave ablation and surgical resection for preoperative T1N0M0 papillary thyroid carcinoma: 5-year follow-up","volume":"36","author":"Fei","year":"2026","journal-title":"Eur Radiol"},{"key":"10.1016\/j.eprac.2026.08.014_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110706","article-title":"Therapeutic outcomes and safety of radiofrequency ablation for primary papillary thyroid carcinoma: a game-changing meta-analysis","volume":"205","author":"Toraih","year":"2025","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.014_bib44","doi-asserted-by":"crossref","DOI":"10.1080\/02656736.2025.2482716","article-title":"Early efficacy of radiofrequency ablation for multifocal T1N0M0 papillary thyroid carcinoma: a multicenter study","volume":"42","author":"Zhu","year":"2025","journal-title":"Int J Hyperthermia"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.014_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S2213-8587(18)30306-1","article-title":"Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial","volume":"7","author":"Dehbi","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.eprac.2026.08.014_bib46","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S2213-8587(18)30113-X","article-title":"Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial","volume":"6","author":"Schlumberger","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10498","key":"10.1016\/j.eprac.2026.08.014_bib47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0140-6736(25)00629-4","article-title":"Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial","volume":"406","author":"Mallick","year":"2025","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.eprac.2026.08.014_bib48","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMoa2111953","article-title":"Thyroidectomy without radioiodine in patients with low-risk thyroid cancer","volume":"386","author":"Leboulleux","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.eprac.2026.08.014_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/10507256251401241","article-title":"Are total thyroidectomy and adjuvant radioactive iodine treatment required in all patients with N1b intermediate-high risk papillary thyroid carcinoma?","volume":"36","author":"Fujiwara","year":"2026","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.eprac.2026.08.014_bib50","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jamaoto.2025.2626","article-title":"Age-specific risk of second primary malignant neoplasm after radioactive iodine treatment for differentiated thyroid cancer","volume":"151","author":"An","year":"2025","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"12","key":"10.1016\/j.eprac.2026.08.014_bib51","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1210\/clinem\/dgaf463","article-title":"TSH cutoffs and recurrence risk in differentiated thyroid carcinomas: a systematic review and meta-analysis","volume":"110","author":"Cho","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2026.08.014_bib52","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.eprac.2025.04.020","article-title":"Use of neck ultrasound as surveillance in older adults with thyroid cancer","volume":"31","author":"Francis-Levin","year":"2025","journal-title":"Endocr Pract"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26011158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26011158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:48:30Z","timestamp":1789764510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26011158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":49,"alternative-id":["S1530891X26011158"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.08.014","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid Year-in-Review 2025-2026: Precision Medicine and De-escalation in Contemporary Thyroidology","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}